Correlation of whole blood hydroxychloroquine concentration with cutaneous lupus erythematosus and factors associated with it: First multicenter, cross‐sectional analysis in Malaysia
暂无分享,去创建一个
J. Stanslas | W. C. Tan | A. L. Lim | S. Thevarajah | K. N. How | W. W. A. Wan Ahmad Kammal | A. Yong | D. Peh | P. J. Beh
[1] M. Liu,et al. Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method , 2021, Frontiers in Pharmacology.
[2] F. Tarazona-Santabalbina,et al. Enfermedad por coronavirus 2019 (COVID-19) y edadismo: revisión narrativa de la literatura , 2020, Revista Española de Geriatría y Gerontología.
[3] M. Marmor,et al. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). , 2016, Ophthalmology.
[4] L. Arnaud,et al. The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study. , 2016, Journal of the American Academy of Dermatology.
[5] X. Mariette,et al. Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus , 2015, Arthritis & rheumatology.
[6] L. Arnaud,et al. Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. , 2015, Journal of the American Academy of Dermatology.
[7] M. Amagai,et al. Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI) , 2013, Modern rheumatology.
[8] J. Jorizzo,et al. Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus , 2012, Clinical and experimental dermatology.
[9] D. Lipsker,et al. Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study. , 2012, Archives of dermatology.
[10] Q. Nguyen,et al. Faculty Opinions recommendation of Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. , 2011 .
[11] A. Troxel,et al. Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus. , 2011, Archives of dermatology.
[12] J. Piette,et al. Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases , 2007, Annals of the rheumatic diseases.
[13] C. Ong,et al. Genetic polymorphism of CYP2C8 in three Malaysian ethnics: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians , 2005, Journal of clinical pharmacy and therapeutics.
[14] S. Wong,et al. Cigarette smoking enhances the elimination of quinine. , 1993, British journal of clinical pharmacology.
[15] Hartmut Derendorf,et al. How Important Are Gender Differences in Pharmacokinetics? , 2002, Clinical pharmacokinetics.
[16] D. Cutler,et al. High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at pH 11, with fluorimetric detection. , 1985, Journal of chromatography.